Lrig1 anticorps (C-Term)

N° du produit ABIN1881506

L’anticorps Lapin Polyclonal anti-Lrig1 a été validé pour WB. Il convient pour détecter Lrig1 dans des échantillons de Souris. Il y a 1 publication disponible.

Aperçu rapide pour Lrig1 anticorps (C-Term) (ABIN1881506)

Antigène: Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Lrig1 est non-conjugé

Application: Western Blotting (WB)

Clone: RB40253

Détail du produit anti-Lrig1 anticorps

Épitope: AA 801-829, C-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This LRIG1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 801-829 amino acids from the C-terminal region of human LRIG1.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-Lrig1 (ABIN1881506)

Ye, Gao, Xu, Zeng, Ou, Mao, Wang, He, Wang, Yang, Guo, Lei: "Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity." dans: Journal of neuro-oncology, Vol. 94, Issue 2, pp. 183-94, (2009) (PubMed).

Détails sur Lrig1

Antigène: Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))

Autre désignation: LRIG1

Sujet: LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.

Poids moléculaire: 119113

NCBI Accession: NP_056356

UniProt: Q96JA1